(Q42432990)

English

Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography

scientific article published on 21 May 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

31 October 2017

Measurement of voriconazole activity against Candida albicans, C. glabrata, and C. parapsilosis isolates using time-kill methods validated by high-performance liquid chromatography (English)

1 reference

Europe PubMed Central

PMC publication ID

31 October 2017

Candida glabrata

0 references

Candida albicans

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Cornelius J Clancy

5

object named as

Cornelius J Clancy

1 reference

Europe PubMed Central

PMC publication ID

31 October 2017

Hartmut Derendorf

3

object named as

Hartmut Derendorf

1 reference

Europe PubMed Central

PMC publication ID

31 October 2017

author name string

Yanjun Li

1

1 reference

Europe PubMed Central

PMC publication ID

31 October 2017

M Hong Nguyen

2

1 reference

Europe PubMed Central

PMC publication ID

31 October 2017

Shaoji Cheng

4

1 reference

Europe PubMed Central

PMC publication ID

31 October 2017

language of work or name

0 references

publication date

21 May 2007

1 reference

Europe PubMed Central

PMC publication ID

31 October 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PMC publication ID

31 October 2017

51

1 reference

Europe PubMed Central

PMC publication ID

31 October 2017

8

1 reference

Europe PubMed Central

PMC publication ID

31 October 2017

2985-2987

1 reference

Europe PubMed Central

PMC publication ID

31 October 2017

describes a project that uses

high-performance liquid chromatography

1 reference

based on heuristic

inferred from title

Characterizing the effects of caspofungin on Candida albicans, Candida parapsilosis, and Candida glabrata isolates by simultaneous time-kill and postantifungal-effect experiments

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932531

28 May 2018

Voriconazole therapeutic drug monitoring.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932531

28 May 2018

Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932531

28 May 2018

Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932531

28 May 2018

Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932531

28 May 2018

In vitro pharmacodynamic characteristics of amphotericin B, caspofungin, fluconazole, and voriconazole against bloodstream isolates of infrequent Candida species from patients with hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932531

28 May 2018

In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932531

28 May 2018

Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932531

28 May 2018

Evaluation of voriconazole pharmacodynamics using time-kill methodology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932531

28 May 2018

Organism-dependent fungicidal activities of azoles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1932531

28 May 2018

A rapid HPLC assay for voriconazole in human plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/17517840

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.00308-07

1 reference

Europe PubMed Central

PMC publication ID

31 October 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

31 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

31 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42432990&oldid=2143452387"